PD-L1 expression pattern in large cell neuroendocrine carcinoma of the lung
Damotte, D., Charpentier, M.C., Bernardi, M., Watkin, E., Goubin Versini, I., Lamy, R., Piton, N., Geriniere, L., Forest, F., Gervais, R., Monnet, I., Madrosyk, A., Guisier, F., Serrand, C., Locher Genty, C., Decroisette, C., Auliac, J.B., Jeanfaivre, T., Doubre, H., Arpin, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14
Auliac, J B, Bayle, S, Vergnenegre, A, Le Caer, H, Falchero, L, Gervais, R, Doubre, H, Vinas, F, Marin, B, Chouaid, C
Published in Current oncology (Toronto) (01.10.2018)
Published in Current oncology (Toronto) (01.10.2018)
Get full text
Journal Article
Combination of Raltitrexed and Oxaliplatin Is an Active Regimen in Malignant Mesothelioma: Results of a Phase II Study
FIZAZI, K, DOUBRE, H, LE CHEVALIER, T, RIVIERE, A, VIALA, J, DANIEL, C, ROBERT, L, BARTHELEMY, P, FANDI, A, RUFFIE, P
Published in Journal of clinical oncology (15.01.2003)
Published in Journal of clinical oncology (15.01.2003)
Get full text
Journal Article
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
Fizazi, K, Caliandro, R, Soulié, P, Fandi, A, Daniel, C, Bedin, A, Doubre, H, Viala, J, Rodier, J.-M, Trandafir, L, Le Chevalier, T, Cvitkovic, E, Armand, J.-P, Ruffié, P
Published in European journal of cancer (1990) (01.08.2000)
Published in European journal of cancer (1990) (01.08.2000)
Get full text
Journal Article
1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)
Descourt, R., Guisier, F., Pérol, M., Cadranel, J., Duruisseaux, M., Doubre, H., Culine, S., Lamour, C., Moro-Sibilot, D., Mennecier, B., Martin, N., Bylicki, O., Chouaid, C., Greillier, L.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1292P A national real-world analysis of ROS1+ metastatic non-small cell lung cancer patients management (explore ALK, cohort 2, GFPC 03-2019)
Rousseau Bussac, G., Guisier, F., Veillon, R., Doubre, H., Cortot, A.B., Moreau, L., Pierret, T., Falchero, L., Justeau, G., Ricordel, C., Morel, H., Amrane, K., Bigay-Game, L., Hominal, S., Martinez, S., Renault, P.A., Moreau, D., Marcq, M., Descourt, R., Greillier, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1286P Explore-ALK (GFPC 03-2019): A real-world prospective, multicenter study of advanced ALK rearranged non-small cell lung cancer patients
Decroisette, C., Descourt, R., Rousseau Bussac, G., Swalduz, A., Bylicki, O., Bigay-Game, L., Doubre, H., Cortot, A.B., Hominal, S., Falchero, L., Guisier, F., Domblides, M., Lamy, R., Pinsolle, J., Ricordel, C., Moreau, D., Martinez, S., Justeau, G., Chouaid, C., Greillier, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1097P Impact of tumor and liquid rebiopsy in metastatic non-small cell lung cancer with EGFR/ALK/ROS oncogenic drivers, progressing after optimal target therapy
Bronstein, A., Gervais, R., Monnet, I., Ricordel, C., Bigay-Game, L., Geier, M., Decroisette, C., Daniel, C., Guisier, F., Swalduz, A., Toffart, A.C., Doubre, H., Peloni, J.M., Arpin, D., Morel, H., Veillon, R., Clarisse, B., Chouaid, C., Greillier, L., Bylicki, O.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
52P Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with non small-cell lung carcinoma (NSCLC): INTEPI, a multicentric retrospective study
Bilger, G., Girard, N., Doubre, H., Levra, M. Giaj, Leprieur, E. Giroux, Giraud, F., Decroisette, C., Livartowski, A., Massiani, M-A.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
1718P A French experience on COVID-19 and cancer from an academic general hospital in Paris area
Laurain, P.A., Landrin, T., Benmaziane Teillet, A., Sekkate, S., Billard, D., Lesprit, P., Couderc, L-J., Friard, S., Doubre, H., Beuzeboc, P., Ratta, R.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1258P MET exon14 skipping in non-small cell lung cancer: Clinicopathological characteristics, treatments, and efficacy of crizotinib according to functional analysis: AFonMET - GFPC study
Babey, H., Jamme, P., Gervais, R., Assié, J-B., Veillon, R., Doubre, H., Pérol, M., Guisier, F., Huchot, E., Decroisette, C., Falchero, L., Chiappa, A-M., André, M., Cortot, A.B., Chouaid, C., Le Gac, G., Descourt, R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1016P GFPC 06-2018: A multicentre phase II, open-label, non-randomized study evaluating platinum-pemetrexed-atezolizumab (+/- bevacizumab) for patients with stage IIIB/IV non-squamous NSCLC with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies
Bylicki, O., Gervais, R., Monnet, I., Ricordel, C., Bigay-Game, L., Geier, M., Decroisette, C., Daniel, C., Guisier, F., Swalduz, A., Toffart, A.C., Doubre, H., Peloni, J.M., Arpin, D., Morel, H., Veillon, R., Clarisse, B., Martins-Lavinas, P-H., Greillier, L., Chouaid, C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1326P Liver metastasis but not bone metastasis impact overall survival of advanced non-small cell lung cancer (NSCLC) treated by nivolumab (GFPC 04-2016)
Decroisette, C., Guisier, F., Bylicki, O., Lamy, R., Geier, M., Morel, H., Bizieux, A., Vieillot, S., Bernardi, M., Janicot, H., Boissiere, L., Justeau, G., Gervais, R., Doubre, H., Le Garff, G., Vergnenegre, A., Chouaid, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Octogenarians with EGFR-mutated non-small cell lung Cancer (NSCLC) treated by Tyrosine Kinase Inhibitor (TKI): A multicentric real world study assessing tolerance and efficacy. OCTOMUT study GFPC 07-15
Corre, R., Gervais, R., Tassy, L., Guisier, F., Lamy, R., Fraboulet, G., Greillier, L., Doubre, H., chouaid, C., Auliac, J.B.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
P2.14-65 Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E–Mutant NSCLC in Real World Setting
Auliac, J.B., Bayle, S., Do, P., Legarff, G., Guisier, F., Roa, M., Falchero, L., Huchon, E., Quere, G., Jeannin, G., Doubre, H., Baud, M., Hobeika, J., Chouaid, C.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
MA03.09 Dramatic Responses to Immune Checkpoint Inhibitors in MET Exon 14 Skipping Mutation (METex14mut) Non Small Cell Lung Cancers
Mayenga, M., Monnet, I., Massiani, M., Assié, J., Tabeze, L., Friard, S., Fraboulet, S., Metivier, A., Chouaid, C., Zemoura, L., Longchampt, E., Melaabi, S., Couderc, L., Doubre, H.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial
Pujol, J.-L., Lavole, A., Quoix, E., Molinier, O., Souquet, P.-J., Barlesi, F., Le Caer, H., Moro-Sibilot, D., Fournel, P., Oster, J.P., Chatellain, P., Barre, P., Jeannin, G., Mourlanette, P., Derollez, M., Herman, D., Renault, A., Dayen, C., Lamy, P.J., Langlais, A., Morin, F., Zalcman, G., Westeel, V., Poudenx, M., Mazieres, J., Martinet, Y., Gury, J-P., Baize, N., Dumont, P., Vaylet, F., Foucher, P., Dauba, J., Tredaniel, J., Laize, H., Petit, L., Coëtmeur, D., Doubre, H., Pichon, E., Schneider, S., Goutorbe, F., Gervais, R., Zaegel, M., Dehette, S., Coudert, B., Duhamel, J-P., Dixmier, A., Thiberville, L., Deguiral, P., Monnot, H., Romand, P., Berard, H., Raspaud, C.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
Baldacci, S., Besse, B., Avrillon, V., Mennecier, B., Dubray-Longeras, P., Mazieres, J., Descourt, R., Duruisseaux, M., Quantin, X., Doubre, H., Monnet, I., Moro-Sibilot, D., Schneider, S., Cousin, S., Merle, P., Otto, J., Langlais, A., Morin, F., Westeel, V., Girard, N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
First results of a high precision mass measurement program for very short-lived nuclides
Toader, C., Monsanglant, C., Audi, G., Conreur, G., Doubre, H., Henry, S., Jacotin, M., Kepinski, J.F., Le Scornet, G., Lunney, D., De Saint Simon, M., Thibault, C., Kluge, H.-J., Borcea, C., Duma, M., Bollen, G.
Published in Nuclear Physics A (22.04.2002)
Published in Nuclear Physics A (22.04.2002)
Get full text
Journal Article
Conference Proceeding
P1.13-09 Efficacy and Tolerance of Osimertinib in Real Word Setting: Results of the French Early Access Program (EXPLORE T790M GFPC Study)
Auliac, J.B., Pérol, M., Planchard, D., Monnet, I., Wislez, M., Doubre, H., Guisier, F., Pichon, E., Greillier, L., Mastroianni, B., Decroissette, C., Schott, R., Le Moulec, S., Arrondeau, J., Cortot, A., Gerinière, L., Renault, A., Daniel, C., Falchero, L., Chouaid, C.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article